The eEF2 kinase coordinates the DNA damage response to cisplatin by supporting p53 activation.

Saved in:
Bibliographic Details
Title: The eEF2 kinase coordinates the DNA damage response to cisplatin by supporting p53 activation.
Authors: Lim JKM; Institute of Neuropathology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Samiei A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, BC, Canada., Delaidelli A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, BC, Canada., de Santis JO; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil., Brinkmann V; Institute of Toxicology, Heinrich Heine University, Düsseldorf, Germany., Carnie CJ; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Radiloff D; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, BC, Canada., Hruby L; Institute of Neuropathology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Kahler A; Institute of Neuropathology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Cran J; Terry Fox Laboratory, BC Cancer Research Institute, Vancouver, BC, Canada., Leprivier G; Institute of Neuropathology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. gabriel.leprivier@med.uni-duesseldorf.de., Sorensen PH; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. psor@mail.ubc.ca.; Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, BC, Canada. psor@mail.ubc.ca.
Source: Cell death & disease [Cell Death Dis] 2024 Jul 13; Vol. 15 (7), pp. 501. Date of Electronic Publication: 2024 Jul 13.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2041-4889
DOI:10.1038/s41419-024-06891-4